Opportunity Information: Apply for PAR 19 389
The National Institutes of Health (NIH) funding opportunity PAR-19-389, titled "Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)," supports exploratory, early-stage research aimed at improving how cancer is detected and diagnosed from medical images. The central idea is that accuracy in radiology and pathology is not driven only by better scanners, stains, or algorithms, but also by how human observers actually see, interpret, and decide based on what is in front of them. This FOA is designed to encourage studies that dig into the perceptual and cognitive processes that shape image interpretation performance, with the practical goal of reducing errors, improving diagnostic accuracy, and ultimately strengthening cancer detection and diagnostic decision-making.
Projects funded under this announcement are expected to focus on understanding and potentially improving the human side of image interpretation. That can include research on visual perception (what features observers notice or miss, how attention is deployed, how image quality and presentation change what is perceived), cognition and decision-making (how observers form judgments under uncertainty, how expertise develops, how memory and expectations influence conclusions, and how biases or heuristics may contribute to misses or false alarms), and workflow or contextual factors that influence performance in real settings. The opportunity is relevant to both radiology and pathology observers, which broadly covers clinicians and others who interpret cancer-related images, including studies that compare different levels of experience or training, or that examine how interpretation changes with different case mixes, time pressure, fatigue, or the way images and clinical information are presented.
The award mechanism is the NIH R21, which is commonly used for exploratory, proof-of-concept, or hypothesis-generating work. In the source details provided, the award ceiling is listed as $200,000, indicating a relatively modest budget compared to large-scale clinical research, consistent with R21 goals of enabling innovative pilot work and establishing feasibility for future larger studies. The FOA is labeled "Clinical Trial Optional," meaning applicants may propose studies that include a clinical trial component if it is appropriate for the research question, but a clinical trial is not required. This flexibility allows for a range of study types, from controlled lab-based observer experiments to applied studies that test interventions intended to improve interpretation, provided the work aligns with the intent of understanding and improving perceptual and cognitive factors in cancer image reading.
A wide range of organizations can apply, reflecting NIH's broad eligibility for many grant programs. Eligible applicants include state, county, and local governments; independent school districts; public and state-controlled universities; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding higher education institutions where relevant); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, eligible federal agencies, and even non-U.S. entities (foreign organizations). In practice, that means the program is open to a diverse applicant pool, including academic labs, medical centers, research institutes, community organizations with relevant expertise, and international groups positioned to study observer performance in cancer imaging contexts.
In terms of administrative identifiers, the opportunity is a discretionary grant program in the education and health activity categories, associated with CFDA numbers 93.394 and 93.395. It was created on 2019-10-02, and the original closing date listed in the provided record is 2023-01-07. Overall, the opportunity is best understood as NIH support for innovative, observer-focused cancer imaging research that connects human perception and cognition to real-world diagnostic performance, with the expectation that insights from this work can inform better training, better interpretation strategies, improved display or workflow approaches, and other interventions that help clinicians and image readers make more accurate cancer-related decisions.Apply for PAR 19 389
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394, 93.395.
- This funding opportunity was created on 2019-10-02.
- Applicants must submit their applications by 2023-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not Allowed)
Previous opportunity: USAID/Burundi Orphans and Vulnerable Children (OVC) Local Activity
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 19 389
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 19 389) also looked into and applied for these:
| Funding Opportunity |
|---|
| Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Apply for PAR 19 387 Funding Number: PAR 19 387 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Strategies to Improve Health Outcomes and to Reduce Disparities in Rural Populations (R01 Clinical Trial Optional) Apply for RFA NR 20 001 Funding Number: RFA NR 20 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trials Optional) Apply for RFA CA 20 001 Funding Number: RFA CA 20 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) Apply for PAR 20 035 Funding Number: PAR 20 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) Apply for PAR 20 034 Funding Number: PAR 20 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Identification, Validation, and Manipulation of Neural Circuits Related to Mental Illness and Alcohol and Substance Use Disorders in Non-human Primates (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 320 Funding Number: RFA MH 20 320 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Apply for PAR 20 043 Funding Number: PAR 20 043 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Assessing the Effects of Cannabinoids on HIV-Induced Inflammation (R01 Clinical Trial Optional) Apply for RFA DA 20 022 Funding Number: RFA DA 20 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional) Apply for PAR 20 052 Funding Number: PAR 20 052 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) Apply for PAR 20 053 Funding Number: PAR 20 053 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition: Biospecimen Bank to Support NCI Early-Phase and Experimental Clinical Trials (U24 Clinical Trials Not Allowed) Apply for RFA CA 20 003 Funding Number: RFA CA 20 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research (U18 - Clinical Trial Not Allowed) Apply for RFA DA 20 025 Funding Number: RFA DA 20 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) Apply for RFA CA 20 015 Funding Number: RFA CA 20 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed) Apply for RFA CA 20 014 Funding Number: RFA CA 20 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Co-infection and Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 20 061 Funding Number: PAR 20 061 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Co-infection and Cancer (R01 Clinical Trial Not Allowed) Apply for PAR 20 062 Funding Number: PAR 20 062 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) Apply for PAR 20 074 Funding Number: PAR 20 074 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed) Apply for PAR 20 076 Funding Number: PAR 20 076 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 20 025 Funding Number: RFA CA 20 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 20 021 Funding Number: RFA CA 20 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 389", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
